Cardiovascular Complications of Hematopoietic Stem Cell Transplantation
Authors:
Open Access
- 24 February 2016
- journal article
- research article
- Published by Springer Nature in Current Treatment Options in Cardiovascular Medicine
- Vol. 18 (4) , 1-10
Abstract
Opinion statement Survivors of hematopoietic stem cell transplant (HSCT) are at significant risk for cardiac disease and cardiac complications. While there may be cardiac complications during the acute period of HSCT, long-term survivors remain at risk for cardiovascular disease at a rate at least fourfold higher than the general population. Aggressive screening for cardiac risk factors such as diabetes, hypertension, and arrhythmias is warranted pretransplant. For those with risk factors, particularly a history of cardiovascular disease or atrial fibrillation, cardiology consultation is warranted in the pretransplantation period. Aggressive screening for cardiac risk factors such as diabetes, hypertension, and hyperlipidemia is warranted in HSCT survivors as well; early and aggressive treatment of left ventricular dysfunction is warranted. Collaboration between hematology/oncology and cardiology through a cardio-oncology clinic is an optimal way to help manage these patients.Keywords
This publication has 62 references indexed in Scilit:
- Two‐ and Three‐Dimensional Speckle Tracking Echocardiography: Clinical Applications and Future DirectionsEchocardiography, 2013
- Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular diseaseBlood, 2012
- Late Cardiac Effects of Cancer TreatmentJournal of Clinical Oncology, 2012
- Atrial fibrillation following autologous stem cell transplantation in patients with multiple myeloma: incidence and risk factorsTherapeutic Advances in Cardiovascular Disease, 2012
- Use of Geriatric Assessment for Older Adults in the Oncology Setting: A Systematic ReviewJNCI: Journal of the National Cancer Institute, 2012
- Incidence and predictors of congestive heart failure after autologous hematopoietic cell transplantationBlood, 2011
- Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor StudyBlood, 2010
- Anthracycline-Induced CardiomyopathyJACC, 2010
- Late Effects in Survivors of Hodgkin and Non-Hodgkin Lymphoma Treated with Autologous Hematopoietic Cell Transplantation: A Report from the Bone Marrow Transplant Survivor StudyTransplantation and Cellular Therapy, 2007
- Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme InhibitionCirculation, 2006